Abstract
Treatment with GM-CSF or G-CSF is becoming widely used in patients with chronic neutropenia, or who are aplastic following chemotherapy or autologous or allogeneic bone marrow transplantation. Recently, some authors have described a phenomenon analogous to cyclic agranulocytosis following treatment with G-CSF in a patient with chronic neutropenia. We wish to describe the same phenomenon in a patient with chronic granulocytic leukemia who received GM-CSF (Sandoz) after T cell depletion in order to accelerate hematological reconstitution.
MeSH terms
-
Agranulocytosis / etiology*
-
Bone Marrow / pathology
-
Bone Marrow Transplantation* / pathology
-
Colony-Stimulating Factors / adverse effects*
-
Female
-
Granulocyte-Macrophage Colony-Stimulating Factor
-
Growth Substances / adverse effects*
-
HLA Antigens
-
Humans
-
Leukemia, Myeloid, Chronic-Phase / immunology
-
Leukemia, Myeloid, Chronic-Phase / surgery*
-
Leukemia, Myeloid, Chronic-Phase / therapy
-
Leukocyte Count
-
Lymphocyte Depletion
-
Middle Aged
-
Neutropenia / blood
-
Neutropenia / etiology*
-
Neutropenia / pathology
-
Periodicity
-
T-Lymphocytes
Substances
-
Colony-Stimulating Factors
-
Growth Substances
-
HLA Antigens
-
Granulocyte-Macrophage Colony-Stimulating Factor